Skip to main content
Log in

5-farnesyloxycoumarin: a potent 15-LOX-1 inhibitor, prevents prostate cancer cell growth

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

In this study, the activity of 15-LOX-1 was first evaluated in two prostate cancer cell lines PC3 and DU145. Considering the enzyme inhibitory potency of 5-farnesyloxycoumarin (5f), the cytotoxic effects of this compound was studied in PC3, DU145 and HFF3 (normal cell line) by MTT assay. Since 5f was more effective on PC3 cells, this cell line was used for further explorations. The chromatin condensation and DNA damage were studied by DAPI staining and comet assay, respectively and cell cycle analysis was performed by propidium iodide staining. Results indicated that 15-LOX-1 activity was very low in DU145 cells. Moreover, PC3 cells were more sensitive to 5f as compared to DU145 cancerous cells, while no significant effect was observed on normal HFF3 cells. Interestingly, the IC50 values of 5f on PC3 cells were similar to cisplatin. DAPI staining showed that 5f induced chromatin condensation in 63 % of PC3 cells. Comet assay also demonstrated 53 % “DNA in tail” for PC3 cells. Finally, 5f induced G0/G1 arrest in PC3 cell cycle. These findings suggest that cytotoxic effects of 5f might be due to the inhibition of 15-LOX-1 in PC3 cell line and, it can be introduced as a potent anticancer compound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Barthomeuf C, Lim S, Iranshahi M, Chollet P (2008) Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine 15:103–111

    Article  CAS  PubMed  Google Scholar 

  • Bilgin HM, Atmaca M, Obay BD, Özekinci S, Taşdemir E, Ketani A (2011) Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats. Exp Toxicol Pathol 63:325–330

    Article  CAS  Google Scholar 

  • Borges F, Roleira F, Milhazes N, Santana L, Uriarte E (2005) Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 12:887–916

    Article  CAS  PubMed  Google Scholar 

  • Borges MFM, Roleira FMF, Villares EU, Penin LS (2008) Simple coumarins: privileged scaffolds in medicinal chemistry. Fron Med Chem 4:23–85

    Google Scholar 

  • Brash AR, Boeglin WE, Chang MS (1997) Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 94:6148–6152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burke JE, Dennis EA (2009) Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 23:49–59

    Article  CAS  PubMed  Google Scholar 

  • Comba A, Pasqualini ME (2009) Primers on molecular pathways lipoxygenases: their role as an oncogenic pathway in pancreatic cancer. Pancreatology 9:724–728

    Article  CAS  PubMed  Google Scholar 

  • Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM et al. (2011) Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res 71:6400–6409

    Article  CAS  PubMed  Google Scholar 

  • Eleftheriadis N, Thee S, Biesebeek J, Wouden P, Baas BJ, Dekker FJ (2015) Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1. Eur J Med Chem 94:265–275

    Article  CAS  PubMed  Google Scholar 

  • Goel A, Prasad AK, Parmar VS, Ghosh B, Saini N (2009) Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: role of NF-kappaB, Akt, ROS and MAP kinase pathway. Chem Biol Interact 179:363–374

    Article  CAS  PubMed  Google Scholar 

  • Gulappa T, Reddy RS, Suman S, Nyakeriga AM, Damodaran C (2013) Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells. Cancer Lett 337:177–183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haghighi F, Matin MM, Bahrami AR, Iranshahi M, Rassouli FB, Haghighitalab A (2014) The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage. DARU 22:1–10

    Article  Google Scholar 

  • Hyde CAC, Missailidis S (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumor-angiogenesis. Int Immunopharmacol 9:701–715

    Article  CAS  PubMed  Google Scholar 

  • Ilic D, Neuberger MM, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev 1:CD004720

    Google Scholar 

  • Iranshahi M, Askari M, Sahebkar A, Hadjipavlou-Litina D (2009) Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. DARU 17:99–103

    CAS  Google Scholar 

  • Iranshahi M, Jabbari A, Orafaie A, Mehri R, Zeraatkar S, Ahmadi T et al. (2012) Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors. Eur J Med Chem 57:134–142

    Article  CAS  PubMed  Google Scholar 

  • Kelavkar UP, Parwani AV, Shappell SB, Martin WD (2006) Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia 8:510–522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB (2004) Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia 6:821–830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF (2001) Overexpression of 15-lipoxygenase-1 in PC3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22:1765–1773

    Article  CAS  PubMed  Google Scholar 

  • Lee SH, Park C, Jin CY, Kim GY, Moon SK, Hyun JW, Lee WH et al. (2008) Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells. Biomed Pharmacother 62:723–729

    Article  CAS  PubMed  Google Scholar 

  • Meng Z, Cao R, Yang Z, Liu T, Wang YZ, Wang X (2013) Inhibitor of 5-Lipoxygenase, Zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and Paxillin. Urology 82:1452.e7–1452.e14

    Article  Google Scholar 

  • Murakami A, Nishizawa T, Egawa K, Kawada T, Nishikawa Y, Uenakai K et al. (2005) New class of linoleic acid metabolites biosynthesized by corn and rice lipoxygenases: suppression of pro-inflammatory mediator expression via attenuation of MAPK and Akt, but not PPARγ dependent pathways in stimulated macrophages. Biochem Pharmacol 70:1330–1342

    Article  CAS  PubMed  Google Scholar 

  • Napagoda M, Gerstmeier J, Wesely S, Popella S, Lorenz S, Scheubert K et al. (2014) Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approach. J Ethnopharmacol 151:800–809

    Article  CAS  PubMed  Google Scholar 

  • Rassouli FB, Matin MM, Iranshahi M, Bahrami AR, Behravan J, Mollazadeh S et al. (2011) Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin. Toxicol In Vitro 25:469–474

    Article  CAS  PubMed  Google Scholar 

  • Ribeiro D, Freitas M, Tomé SM, Silva AMS, Porto G, Cabrita EJ et al. (2014) Inhibition of LOX by flavonoids: a structure–activity relationship study. Eur J Med Chem 72:137–145

    Article  CAS  PubMed  Google Scholar 

  • Riveiro ME, Moglioni A, Vazquez R, Gomez N, Facorro G, Piehl L et al. (2008) Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg Med Chem 16:2665–2675

    Article  CAS  PubMed  Google Scholar 

  • Sadeghian H, Seyedi SM, Saberi MR, Arghiani Z, Riazi M (2008) Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem 16:890–901

    Article  CAS  PubMed  Google Scholar 

  • Sadeghian H, Attaran N, Jafari Z, Saberi MR, Pordel M, Riazi MM (2009) Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them. Bioorg Med Chem 17:2327–2335

    Article  CAS  PubMed  Google Scholar 

  • Schneider C, Pozzi A (2011) Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Rev 30:277–294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C et al. (2001) 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 61:497–503

    CAS  PubMed  Google Scholar 

  • Spindler SA, Sarkar FH, Sakr WA, Blackburn ML, Bull AW, La Gattuta M, Reddy RG (1997) Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun 239:775–781

    Article  CAS  PubMed  Google Scholar 

  • Tehrani MB, Emami S, Asadi M, Saeedi M, Mirzahekmati M, Ebrahimi SM et al. (2014) Imidazo [2,1-b] thiazole derivatives as new inhibitors of 15-lipoxygenase. Eur J Med Chem 87:759–764

    Article  CAS  PubMed  Google Scholar 

  • Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181–193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang CJ, Hsieh YJ, Chu CY, Lin YL, Tseng TH (2002) Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett 183:163–168

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto S, Suzuki H, Nakamura M, Ishimura K (1999) Arachidonate 12-lipoxygenase isozymes. Adv Exp Med Biol 447:37–44

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from Ferdowsi University of Mashhad. The authors would like to thank Dr. Behnam—Rassouli, Mr. Malaekeh—Nikouei and Mr. Nakhaei for their excellent support and technical help.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maryam M. Matin.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orafaie, A., Sadeghian, H., Bahrami, A.R. et al. 5-farnesyloxycoumarin: a potent 15-LOX-1 inhibitor, prevents prostate cancer cell growth. Med Chem Res 26, 227–234 (2017). https://doi.org/10.1007/s00044-016-1737-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-016-1737-1

Keywords

Navigation